HomeKYTX • NASDAQ
add
Kyverna Therapeutics Inc
Previous close
$5.65
Day range
$5.50 - $5.77
Year range
$4.40 - $35.03
Market cap
243.35M USD
Avg Volume
418.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.11M | — |
Net income | -28.80M | — |
Net profit margin | — | — |
Earnings per share | -0.67 | — |
EBITDA | -33.14M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 346.24M | — |
Total assets | 363.12M | — |
Total liabilities | 29.61M | — |
Total equity | 333.51M | — |
Shares outstanding | 43.15M | — |
Price to book | 0.73 | — |
Return on assets | -22.20% | — |
Return on capital | -23.37% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -28.80M | — |
Cash from operations | -24.18M | — |
Cash from investing | -67.92M | — |
Cash from financing | -569.00K | — |
Net change in cash | -92.66M | — |
Free cash flow | -15.57M | — |
About
Founded
2018
Headquarters
Website
Employees
112
